Volatile Organic Compounds in Exhaled Breath as Fingerprints of Lung Cancer, Asthma and COPD
- PMID: 33374433
- PMCID: PMC7796324
- DOI: 10.3390/jcm10010032
Volatile Organic Compounds in Exhaled Breath as Fingerprints of Lung Cancer, Asthma and COPD
Abstract
Lung cancer, chronic obstructive pulmonary disease (COPD) and asthma are inflammatory diseases that have risen worldwide, posing a major public health issue, encompassing not only physical and psychological morbidity and mortality, but also incurring significant societal costs. The leading cause of death worldwide by cancer is that of the lung, which, in large part, is a result of the disease often not being detected until a late stage. Although COPD and asthma are conditions with considerably lower mortality, they are extremely distressful to people and involve high healthcare overheads. Moreover, for these diseases, diagnostic methods are not only costly but are also invasive, thereby adding to people's stress. It has been appreciated for many decades that the analysis of trace volatile organic compounds (VOCs) in exhaled breath could potentially provide cheaper, rapid, and non-invasive screening procedures to diagnose and monitor the above diseases of the lung. However, after decades of research associated with breath biomarker discovery, no breath VOC tests are clinically available. Reasons for this include the little consensus as to which breath volatiles (or pattern of volatiles) can be used to discriminate people with lung diseases, and our limited understanding of the biological origin of the identified VOCs. Lung disease diagnosis using breath VOCs is challenging. Nevertheless, the numerous studies of breath volatiles and lung disease provide guidance as to what volatiles need further investigation for use in differential diagnosis, highlight the urgent need for non-invasive clinical breath tests, illustrate the way forward for future studies, and provide significant guidance to achieve the goal of developing non-invasive diagnostic tests for lung disease. This review provides an overview of these issues from evaluating key studies that have been undertaken in the years 2010-2019, in order to present objective and comprehensive updated information that presents the progress that has been made in this field. The potential of this approach is highlighted, while strengths, weaknesses, opportunities, and threats are discussed. This review will be of interest to chemists, biologists, medical doctors and researchers involved in the development of analytical instruments for breath diagnosis.
Keywords: analytical platforms; asthma; chronic obstructive pulmonary disease; lung cancer; markers of respiratory diseases.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/7796324/bin/jcm-10-00032-g001.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/7796324/bin/jcm-10-00032-g002.gif)
![Figure 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/7796324/bin/jcm-10-00032-g003.gif)
![Figure 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/7796324/bin/jcm-10-00032-g004.gif)
![Figure 5](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/7796324/bin/jcm-10-00032-g005.gif)
![Figure 6](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/7796324/bin/jcm-10-00032-g006.gif)
Similar articles
-
Analyses of lung cancer-derived volatiles in exhaled breath and in vitro models.Exp Biol Med (Maywood). 2022 Jul;247(13):1179-1190. doi: 10.1177/15353702221082634. Epub 2022 Apr 11. Exp Biol Med (Maywood). 2022. PMID: 35410512 Free PMC article. Review.
-
Analysis of volatile organic compounds in the breath of patients with stable or acute exacerbation of chronic obstructive pulmonary disease.J Breath Res. 2018 Mar 6;12(3):036002. doi: 10.1088/1752-7163/aaa4c5. J Breath Res. 2018. PMID: 29295966
-
Exhaled breath condensate: determination of non-volatile compounds and their potential for clinical diagnosis and monitoring. A review.Anal Chim Acta. 2013 Dec 17;805:1-18. doi: 10.1016/j.aca.2013.07.049. Epub 2013 Jul 31. Anal Chim Acta. 2013. PMID: 24296139 Review.
-
An electronic nose in the discrimination of patients with non-small cell lung cancer and COPD.Lung Cancer. 2009 May;64(2):166-70. doi: 10.1016/j.lungcan.2008.08.008. Epub 2008 Oct 1. Lung Cancer. 2009. PMID: 18834643
-
Biomarkers of some pulmonary diseases in exhaled breath.Biomarkers. 2002 Jan-Feb;7(1):1-32. doi: 10.1080/13547500110104233. Biomarkers. 2002. PMID: 12101782 Review.
Cited by
-
Urinary volatile organic compound metabolites and COPD among US adults: mixture, interaction and mediation analysis.Environ Health. 2024 May 3;23(1):45. doi: 10.1186/s12940-024-01086-y. Environ Health. 2024. PMID: 38702703 Free PMC article.
-
Early-life house dust mite aeroallergen exposure augments cigarette smoke-induced myeloid inflammation and emphysema in mice.Respir Res. 2024 Apr 13;25(1):161. doi: 10.1186/s12931-024-02774-6. Respir Res. 2024. PMID: 38614991 Free PMC article.
-
Plasmonic Alloys Enhanced Metabolic Fingerprints for the Diagnosis of COPD and Exacerbations.ACS Cent Sci. 2024 Jan 27;10(2):331-343. doi: 10.1021/acscentsci.3c01201. eCollection 2024 Feb 28. ACS Cent Sci. 2024. PMID: 38435520 Free PMC article.
-
New perspectives on 'Breathomics': metabolomic profiling of non-volatile organic compounds in exhaled breath using DI-FT-ICR-MS.Commun Biol. 2024 Mar 2;7(1):258. doi: 10.1038/s42003-024-05943-x. Commun Biol. 2024. PMID: 38431745 Free PMC article.
-
Noninvasive Diabetes Detection through Human Breath Using TinyML-Powered E-Nose.Sensors (Basel). 2024 Feb 17;24(4):1294. doi: 10.3390/s24041294. Sensors (Basel). 2024. PMID: 38400451 Free PMC article.
References
-
- Garwood P. World No Tobacco Day 2019: Don’t Let Tobacco Take Your Breath Away. World Health Organization; Geneva, Switzerland: 2019. News Release.
-
- Wang H., Naghavi M., Allen C., Barber R.M., Carter A., Casey D.C., Charlson F.J., Chen A.Z., Coates M.M., Coggeshall M., et al. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: A systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388:1459–1544. doi: 10.1016/S0140-6736(16)31012-1. - DOI - PMC - PubMed
-
- Vos T., Allen C., Arora M., Barber R.M., Brown A., Carter A., Casey D.C., Charlson F.J., Chen A.Z., Coggeshall M., et al. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: A systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388:1545–1602. doi: 10.1016/S0140-6736(16)31678-6. - DOI - PMC - PubMed
-
- Pajewska-Szmyt M., Sinkiewicz-Darol E., Bernatowicz-Łojko U., Kowalkowski T., Gadzała-Kopciuch R., Buszewski B. QuEChERS extraction coupled to GC-MS for a fast determination of polychlorinated biphenyls in breast milk from Polish women. Environ. Sci. Pollut. Res. 2019;26:30988–30999. doi: 10.1007/s11356-019-06201-y. - DOI - PMC - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources